Review



control strain e coli atcc 25922  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC control strain e coli atcc 25922
    EC 50 results for Vibrio strains against GATR-3, LL-37-NH 2 , and Mastoparan-AF-NH 2 peptides. Vibrio vulnificus MO6 EC 50 results against A. GATR-3, B. LL-37-NH 2 , and C. Mastoparan-AF-NH 2 peptides. Vibrio vulnificus JY1701 EC 50 results against D. GATR-3, E. LL-37-NH 2 , and F. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus NY477 EC 50 results against G. GATR-3, H. LL-37-NH 2 , and I. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus SAK11 EC 50 results against J. GATR-3, K. LL-37-NH 2 , and L. Mastoparan-AF-NH 2 peptides. <t>Escherichia</t> <t>coli</t> EC 50 results against M. GATR-3, N. LL-37-NH 2 , and O. Mastoparan-AF-NH 2 peptides.
    Control Strain E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 5672 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+strain+e+coli+atcc+25922/Escherichia+coli/pmc12756713-199-2-6
    Average 99 stars, based on 5672 article reviews
    control strain e coli atcc 25922 - by Bioz Stars, 2026-09
    99/100 stars

    Images

    1) Product Images from "The synthetic peptide GATR-3 shows significant antibacterial and biofilm-inhibition activity against shellfish- and oyster-associated bacteria Vibrio vulnificus and Vibrio parahaemolyticus"

    Article Title: The synthetic peptide GATR-3 shows significant antibacterial and biofilm-inhibition activity against shellfish- and oyster-associated bacteria Vibrio vulnificus and Vibrio parahaemolyticus

    Journal: Comparative Immunology Reports

    doi: 10.1016/j.cirep.2025.200266

    EC 50 results for Vibrio strains against GATR-3, LL-37-NH 2 , and Mastoparan-AF-NH 2 peptides. Vibrio vulnificus MO6 EC 50 results against A. GATR-3, B. LL-37-NH 2 , and C. Mastoparan-AF-NH 2 peptides. Vibrio vulnificus JY1701 EC 50 results against D. GATR-3, E. LL-37-NH 2 , and F. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus NY477 EC 50 results against G. GATR-3, H. LL-37-NH 2 , and I. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus SAK11 EC 50 results against J. GATR-3, K. LL-37-NH 2 , and L. Mastoparan-AF-NH 2 peptides. Escherichia coli EC 50 results against M. GATR-3, N. LL-37-NH 2 , and O. Mastoparan-AF-NH 2 peptides.
    Figure Legend Snippet: EC 50 results for Vibrio strains against GATR-3, LL-37-NH 2 , and Mastoparan-AF-NH 2 peptides. Vibrio vulnificus MO6 EC 50 results against A. GATR-3, B. LL-37-NH 2 , and C. Mastoparan-AF-NH 2 peptides. Vibrio vulnificus JY1701 EC 50 results against D. GATR-3, E. LL-37-NH 2 , and F. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus NY477 EC 50 results against G. GATR-3, H. LL-37-NH 2 , and I. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus SAK11 EC 50 results against J. GATR-3, K. LL-37-NH 2 , and L. Mastoparan-AF-NH 2 peptides. Escherichia coli EC 50 results against M. GATR-3, N. LL-37-NH 2 , and O. Mastoparan-AF-NH 2 peptides.

    Techniques Used:

    Biofilm Formation of Vibrio isolates and E. coli . Quantitative comparison of biofilm formation among Vibrio isolates and E. coli after 24 h incubation. Biofilm biomass was determined by crystal violet staining and measurement of OD₆₀₀. V. vulnificus MO6 and V. parahaemolyticus NY477 exhibited the highest biofilm-forming capacities.
    Figure Legend Snippet: Biofilm Formation of Vibrio isolates and E. coli . Quantitative comparison of biofilm formation among Vibrio isolates and E. coli after 24 h incubation. Biofilm biomass was determined by crystal violet staining and measurement of OD₆₀₀. V. vulnificus MO6 and V. parahaemolyticus NY477 exhibited the highest biofilm-forming capacities.

    Techniques Used: Comparison, Incubation, Staining

    Related Articles

    Control:

    Article Title: Antimicrobial resistance in wildlife: Associations with environmental factors and taxonomic variation.
    Article Snippet: .. As control strain E. coli ATCC 25922 was used (Remel Inc., Lenexa, USA). .. Each E. coli isolate was cultivated on brain-heart infusion agar plates (BHI) supplemented with 5 % sheep blood (Bio Rad, Marnes-la-Coquette, France) and incubated at 35 ± 2 ◦C overnight to facilitate growth.

    Article Title: The synthetic peptide GATR-3 shows significant antibacterial and biofilm-inhibition activity against shellfish- and oyster-associated bacteria Vibrio vulnificus and Vibrio parahaemolyticus
    Article Snippet: .. Against the control strain E. coli ATCC 25922, GATR-3 was extremely potent, with an EC50 of 4.44 × 10−5 μM (1.27 × 10−4 μg/mL), confirming its broad-spectrum and potent efficacy. ..

    Article Title: Diarrheagenic and ESBL Potential of Escherichia coli From Publicly Shared Common Touch Surfaces.
    Article Snippet: .. Results were validated with the control strain E. coli ATCC 25922. .. Phenotypic identification of ESBL‐producing E. coli was performed using the double‐disk synergy test (DDST) in accordance with CLSI guidelines (Clinical and Laboratory Standards Institute [CLSI] 2018).

    Article Title: Biphasic bactericidal activity of nitroxoline against Acinetobacter baumannii assessed by Raman-DIP.
    Article Snippet: The increasing antimicrobial resistance (AMR) of Acinetobacter baumannii presents a challenge to clinical management and underscores its role as a critical pathogen in refractory urinary tract infections (UTIs).. Nitroxoline has gained renewed interest as a potential therapeutic option.. Raman deuterium stable isotope probing (RamanDIP), which allows for the analysis of bacterial metabolic activity, has shown promise as a tool for assessing antimicrobial efficacy.

    Article Title: Reducing the allergenicity of αs1-casein by Lactiplantibacillus plantarum JY067 fermentation.
    Article Snippet: αs1-casein is one of the core allergens in milk allergy, posing a significant risk for infants due to its high content and absence in breast milk.. Consequently, reducing the allergenicity of αs1-casein has become a critical issue in the dairy industry.. This study identified a strain, Lactiplantibacillus plantarum (L. plantarum) JY067, capable of significantly reducing the allergenicity of αs1-casein (the antigen suppression rate was 72.27 %).

    Article Title: Diarrheagenic and ESBL Potential of Escherichia coli From Publicly Shared Common Touch Surfaces
    Article Snippet: .. Results were validated with the control strain E. coli ATCC 25922. .. Phenotypic identification of ESBL‐producing E. coli was performed using the double‐disk synergy test (DDST) in accordance with CLSI guidelines (Clinical and Laboratory Standards Institute [CLSI] ).

    Article Title: A Review on the Current and Future State of Urinary Tract Infection Diagnostics
    Article Snippet: .. The procedure involves incubating the bacteria in the presence of an imipenem disk, followed by transferring the suspension onto an agar plate inoculated with the standard control strain E. coli ATCC 25922, which is susceptible to carbapenems. ..

    Negative Control:

    Article Title: resaCPE: a rapid, low-cost colorimetric assay for the detection of carbapenemase-producing Enterobacterales.
    Article Snippet: .. In UV-Vis spectrophotometric analyses, the K. pneumoniae AR0039 strain that tested false-positive in both the resaCPE and mCIM tests exhibited a significant reduction in absorbance at 297 nm compared to the negative control strain E. coli ATCC 25922 (Fig. S5), which could suggest that the level of ESBL production by this strain binds to a sufficient amount of the carbapenem antibiotic to permit survival of the susceptible indicator strains in both testing methods. ..

    Incubation:

    Article Title: Reducing the allergenicity of αs1-casein by Lactiplantibacillus plantarum JY067 fermentation.
    Article Snippet: αs1-casein is one of the core allergens in milk allergy, posing a significant risk for infants due to its high content and absence in breast milk.. Consequently, reducing the allergenicity of αs1-casein has become a critical issue in the dairy industry.. This study identified a strain, Lactiplantibacillus plantarum (L. plantarum) JY067, capable of significantly reducing the allergenicity of αs1-casein (the antigen suppression rate was 72.27 %).

    Bacteria:

    Article Title: A Review on the Current and Future State of Urinary Tract Infection Diagnostics
    Article Snippet: .. The procedure involves incubating the bacteria in the presence of an imipenem disk, followed by transferring the suspension onto an agar plate inoculated with the standard control strain E. coli ATCC 25922, which is susceptible to carbapenems. ..

    Transferring:

    Article Title: A Review on the Current and Future State of Urinary Tract Infection Diagnostics
    Article Snippet: .. The procedure involves incubating the bacteria in the presence of an imipenem disk, followed by transferring the suspension onto an agar plate inoculated with the standard control strain E. coli ATCC 25922, which is susceptible to carbapenems. ..

    Suspension:

    Article Title: A Review on the Current and Future State of Urinary Tract Infection Diagnostics
    Article Snippet: .. The procedure involves incubating the bacteria in the presence of an imipenem disk, followed by transferring the suspension onto an agar plate inoculated with the standard control strain E. coli ATCC 25922, which is susceptible to carbapenems. ..



    Similar Products

    99
    ATCC control strain e coli atcc 25922
    EC 50 results for Vibrio strains against GATR-3, LL-37-NH 2 , and Mastoparan-AF-NH 2 peptides. Vibrio vulnificus MO6 EC 50 results against A. GATR-3, B. LL-37-NH 2 , and C. Mastoparan-AF-NH 2 peptides. Vibrio vulnificus JY1701 EC 50 results against D. GATR-3, E. LL-37-NH 2 , and F. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus NY477 EC 50 results against G. GATR-3, H. LL-37-NH 2 , and I. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus SAK11 EC 50 results against J. GATR-3, K. LL-37-NH 2 , and L. Mastoparan-AF-NH 2 peptides. <t>Escherichia</t> <t>coli</t> EC 50 results against M. GATR-3, N. LL-37-NH 2 , and O. Mastoparan-AF-NH 2 peptides.
    Control Strain E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+strain+e+coli+atcc+25922/Escherichia+coli/pmc12756713-199-2-6
    Average 99 stars, based on 1 article reviews
    control strain e coli atcc 25922 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    ATCC quality control strain e coli atcc 25922
    EC 50 results for Vibrio strains against GATR-3, LL-37-NH 2 , and Mastoparan-AF-NH 2 peptides. Vibrio vulnificus MO6 EC 50 results against A. GATR-3, B. LL-37-NH 2 , and C. Mastoparan-AF-NH 2 peptides. Vibrio vulnificus JY1701 EC 50 results against D. GATR-3, E. LL-37-NH 2 , and F. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus NY477 EC 50 results against G. GATR-3, H. LL-37-NH 2 , and I. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus SAK11 EC 50 results against J. GATR-3, K. LL-37-NH 2 , and L. Mastoparan-AF-NH 2 peptides. <t>Escherichia</t> <t>coli</t> EC 50 results against M. GATR-3, N. LL-37-NH 2 , and O. Mastoparan-AF-NH 2 peptides.
    Quality Control Strain E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+strain+e+coli+atcc+25922/Escherichia+coli/pm41785227-95-7-12
    Average 99 stars, based on 1 article reviews
    quality control strain e coli atcc 25922 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    ATCC quality control 155 strain e coli atcc 25922
    EC 50 results for Vibrio strains against GATR-3, LL-37-NH 2 , and Mastoparan-AF-NH 2 peptides. Vibrio vulnificus MO6 EC 50 results against A. GATR-3, B. LL-37-NH 2 , and C. Mastoparan-AF-NH 2 peptides. Vibrio vulnificus JY1701 EC 50 results against D. GATR-3, E. LL-37-NH 2 , and F. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus NY477 EC 50 results against G. GATR-3, H. LL-37-NH 2 , and I. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus SAK11 EC 50 results against J. GATR-3, K. LL-37-NH 2 , and L. Mastoparan-AF-NH 2 peptides. <t>Escherichia</t> <t>coli</t> EC 50 results against M. GATR-3, N. LL-37-NH 2 , and O. Mastoparan-AF-NH 2 peptides.
    Quality Control 155 Strain E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+strain+e+coli+atcc+25922/Escherichia+coli/pm41714334-71-0-6
    Average 99 stars, based on 1 article reviews
    quality control 155 strain e coli atcc 25922 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    ATCC quality control strains e coli atcc 25922
    Antimicrobial susceptibility profiles and efficacy of TE-CuONPs against MDR bacterial pathogens. a Inhibition zone diameters for four MDR bacterial strains against conventional antibiotics b - e Disk diffusion assays for E. faecalis , S. aureus , <t>E.</t> <t>coli</t> , and P. aeruginosa (disk positions: 1 = tetracycline, 2 = ampicillin, 3 = norfloxacin, 4 = gentamicin), confirming MDR phenotypes with gentamicin susceptibility only. f Comparative analysis showing TE-CuONPs activity (17.5–18.5 mm) significantly exceeds TE alone (5.5–8.5 mm, p < 0.05) and approaches gentamicin efficacy (20.0–25.0 mm). g MIC and MBC values demonstrating bactericidal activity of TE-CuONPs (MBC/MIC ≤ 0.58) against S. aureus , P. aeruginosa , and E. coli , with bacteriostatic response for E. faecalis (MBC/MIC > 1.05). h Schematic proposal for antimicrobial mechanisms. Different letters indicate statistical significance ( p < 0.05, ANOVA/Tukey). TE-CuONPs exhibit multimechanistic antibacterial activity through ROS generation, membrane disruption, and cellular interference
    Quality Control Strains E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+strain+e+coli+atcc+25922/Escherichia+coli/pmc12891328-180-0-6
    Average 99 stars, based on 1 article reviews
    quality control strains e coli atcc 25922 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    ATCC reference quality control strains e coli atcc 25922
    Antimicrobial susceptibility profiles and efficacy of TE-CuONPs against MDR bacterial pathogens. a Inhibition zone diameters for four MDR bacterial strains against conventional antibiotics b - e Disk diffusion assays for E. faecalis , S. aureus , <t>E.</t> <t>coli</t> , and P. aeruginosa (disk positions: 1 = tetracycline, 2 = ampicillin, 3 = norfloxacin, 4 = gentamicin), confirming MDR phenotypes with gentamicin susceptibility only. f Comparative analysis showing TE-CuONPs activity (17.5–18.5 mm) significantly exceeds TE alone (5.5–8.5 mm, p < 0.05) and approaches gentamicin efficacy (20.0–25.0 mm). g MIC and MBC values demonstrating bactericidal activity of TE-CuONPs (MBC/MIC ≤ 0.58) against S. aureus , P. aeruginosa , and E. coli , with bacteriostatic response for E. faecalis (MBC/MIC > 1.05). h Schematic proposal for antimicrobial mechanisms. Different letters indicate statistical significance ( p < 0.05, ANOVA/Tukey). TE-CuONPs exhibit multimechanistic antibacterial activity through ROS generation, membrane disruption, and cellular interference
    Reference Quality Control Strains E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+strain+e+coli+atcc+25922/Escherichia+coli/pmc12890440-67-4-9
    Average 99 stars, based on 1 article reviews
    reference quality control strains e coli atcc 25922 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    Image Search Results


    EC 50 results for Vibrio strains against GATR-3, LL-37-NH 2 , and Mastoparan-AF-NH 2 peptides. Vibrio vulnificus MO6 EC 50 results against A. GATR-3, B. LL-37-NH 2 , and C. Mastoparan-AF-NH 2 peptides. Vibrio vulnificus JY1701 EC 50 results against D. GATR-3, E. LL-37-NH 2 , and F. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus NY477 EC 50 results against G. GATR-3, H. LL-37-NH 2 , and I. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus SAK11 EC 50 results against J. GATR-3, K. LL-37-NH 2 , and L. Mastoparan-AF-NH 2 peptides. Escherichia coli EC 50 results against M. GATR-3, N. LL-37-NH 2 , and O. Mastoparan-AF-NH 2 peptides.

    Journal: Comparative Immunology Reports

    Article Title: The synthetic peptide GATR-3 shows significant antibacterial and biofilm-inhibition activity against shellfish- and oyster-associated bacteria Vibrio vulnificus and Vibrio parahaemolyticus

    doi: 10.1016/j.cirep.2025.200266

    Figure Lengend Snippet: EC 50 results for Vibrio strains against GATR-3, LL-37-NH 2 , and Mastoparan-AF-NH 2 peptides. Vibrio vulnificus MO6 EC 50 results against A. GATR-3, B. LL-37-NH 2 , and C. Mastoparan-AF-NH 2 peptides. Vibrio vulnificus JY1701 EC 50 results against D. GATR-3, E. LL-37-NH 2 , and F. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus NY477 EC 50 results against G. GATR-3, H. LL-37-NH 2 , and I. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus SAK11 EC 50 results against J. GATR-3, K. LL-37-NH 2 , and L. Mastoparan-AF-NH 2 peptides. Escherichia coli EC 50 results against M. GATR-3, N. LL-37-NH 2 , and O. Mastoparan-AF-NH 2 peptides.

    Article Snippet: Against the control strain E. coli ATCC 25922, GATR-3 was extremely potent, with an EC50 of 4.44 × 10−5 μM (1.27 × 10−4 μg/mL), confirming its broad-spectrum and potent efficacy.

    Techniques:

    Biofilm Formation of Vibrio isolates and E. coli . Quantitative comparison of biofilm formation among Vibrio isolates and E. coli after 24 h incubation. Biofilm biomass was determined by crystal violet staining and measurement of OD₆₀₀. V. vulnificus MO6 and V. parahaemolyticus NY477 exhibited the highest biofilm-forming capacities.

    Journal: Comparative Immunology Reports

    Article Title: The synthetic peptide GATR-3 shows significant antibacterial and biofilm-inhibition activity against shellfish- and oyster-associated bacteria Vibrio vulnificus and Vibrio parahaemolyticus

    doi: 10.1016/j.cirep.2025.200266

    Figure Lengend Snippet: Biofilm Formation of Vibrio isolates and E. coli . Quantitative comparison of biofilm formation among Vibrio isolates and E. coli after 24 h incubation. Biofilm biomass was determined by crystal violet staining and measurement of OD₆₀₀. V. vulnificus MO6 and V. parahaemolyticus NY477 exhibited the highest biofilm-forming capacities.

    Article Snippet: Against the control strain E. coli ATCC 25922, GATR-3 was extremely potent, with an EC50 of 4.44 × 10−5 μM (1.27 × 10−4 μg/mL), confirming its broad-spectrum and potent efficacy.

    Techniques: Comparison, Incubation, Staining

    Antimicrobial susceptibility profiles and efficacy of TE-CuONPs against MDR bacterial pathogens. a Inhibition zone diameters for four MDR bacterial strains against conventional antibiotics b - e Disk diffusion assays for E. faecalis , S. aureus , E. coli , and P. aeruginosa (disk positions: 1 = tetracycline, 2 = ampicillin, 3 = norfloxacin, 4 = gentamicin), confirming MDR phenotypes with gentamicin susceptibility only. f Comparative analysis showing TE-CuONPs activity (17.5–18.5 mm) significantly exceeds TE alone (5.5–8.5 mm, p < 0.05) and approaches gentamicin efficacy (20.0–25.0 mm). g MIC and MBC values demonstrating bactericidal activity of TE-CuONPs (MBC/MIC ≤ 0.58) against S. aureus , P. aeruginosa , and E. coli , with bacteriostatic response for E. faecalis (MBC/MIC > 1.05). h Schematic proposal for antimicrobial mechanisms. Different letters indicate statistical significance ( p < 0.05, ANOVA/Tukey). TE-CuONPs exhibit multimechanistic antibacterial activity through ROS generation, membrane disruption, and cellular interference

    Journal: Bioresources and Bioprocessing

    Article Title: Box-Behnken optimized copper oxide nanoparticles from Thymus vulgaris potentiate efficacy against multidrug-resistant bacterial pathogens and exhibit anticancer activity

    doi: 10.1186/s40643-026-01008-5

    Figure Lengend Snippet: Antimicrobial susceptibility profiles and efficacy of TE-CuONPs against MDR bacterial pathogens. a Inhibition zone diameters for four MDR bacterial strains against conventional antibiotics b - e Disk diffusion assays for E. faecalis , S. aureus , E. coli , and P. aeruginosa (disk positions: 1 = tetracycline, 2 = ampicillin, 3 = norfloxacin, 4 = gentamicin), confirming MDR phenotypes with gentamicin susceptibility only. f Comparative analysis showing TE-CuONPs activity (17.5–18.5 mm) significantly exceeds TE alone (5.5–8.5 mm, p < 0.05) and approaches gentamicin efficacy (20.0–25.0 mm). g MIC and MBC values demonstrating bactericidal activity of TE-CuONPs (MBC/MIC ≤ 0.58) against S. aureus , P. aeruginosa , and E. coli , with bacteriostatic response for E. faecalis (MBC/MIC > 1.05). h Schematic proposal for antimicrobial mechanisms. Different letters indicate statistical significance ( p < 0.05, ANOVA/Tukey). TE-CuONPs exhibit multimechanistic antibacterial activity through ROS generation, membrane disruption, and cellular interference

    Article Snippet: Quality control strains - E. coli ATCC 25922, S. aureus ATCC 25923, and P. aeruginosa ATCC 27853—were included in each experimental run to ensure test reliability.

    Techniques: Inhibition, Diffusion-based Assay, Activity Assay, Membrane, Disruption